Aperio Technologies, Inc. Launches Advanced Digital Pathology Solution for Tissue Microarray Analysis and Research

VISTA, Calif.--(BUSINESS WIRE)--Aperio Technologies, Inc., the leading provider of digital pathology systems and services for the healthcare and life sciences industry, has launched TMALab II, the latest release of the company’s web-based digital pathology information management system, built specifically for researchers who use Tissue Microarrays (TMAs). With this release, Aperio continues to build upon its commitment to develop digital pathology solutions that meet the evolving needs of pathologists, researchers, and laboratories around the world.

MORE ON THIS TOPIC